来源：市场资讯 针对上述提问，国际医学回应称："您好，感谢您对公司的关注。公司控股股东参与前次定增及后续转 让股份均遵循《证券法》《上市公司证券发行管理办法》等法规，程序合法、定价公允，与受让方无关 联关系。控股股东与广大投资者的利益是一致的，长期以来，也一直通过各种方式支持上市公司发展。 谢谢！" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 有投资者在互动平台向国际医学提问："贵公司大股东2021年定增10亿后，2023-2024大股东通过济南铁 岭等公司套现收回10多亿投资，外加近2亿股股份，请问这样套路股民和投资人你们好意思吗？" ...

Core Viewpoint - The company is currently in the business expansion phase for its elderly care facility, with a dynamic adjustment of bed usage based on future planning and development momentum [2]. Group 1 - The company has received inquiries regarding the usage rate of 200 elderly care beds starting in 2025 [2]. - The elderly care facility at Xi'an International Medical Center Hospital is set to open in May 2025 and is experiencing positive growth [2]. - Bed usage will be adjusted dynamically according to the development situation and future plans [2].

Market Overview - On January 13, the A-share market saw a collective decline in the three major indices, with the Shanghai Composite Index closing at 4163.84 points, down 0.03% [2] - The Shenzhen Component Index fell by 0.31%, and the ChiNext Index decreased by 0.83% [2][3] - A total of 2427 stocks rose while 2862 stocks fell, indicating a mixed market sentiment [3] Sector Performance - The healthcare services, lithium mining, precious metals, and insurance sectors showed strong performance, while sectors such as commercial aerospace, communication equipment, and shipbuilding faced declines [3][4] - Lithium mining stocks experienced a significant surge, with companies like Tibet Summit reaching a 10% limit up, and others like Salt Lake Co. and Ganfeng Lithium rising over 7% [6][7] Lithium Mining Sector - The lithium mining sector saw a notable rally, with the main contract for lithium carbonate futures on the Shanghai Futures Exchange surpassing 170,000 yuan per ton, marking a rise of over 9% [6] - Key stocks in this sector include: - Tibet Summit: 19.49 yuan, up 9.99%, market cap of 17.8 billion yuan - Ganfeng Lithium: 72.83 yuan, up 7.15%, market cap of 144.5 billion yuan - Salt Lake Co.: 34.24 yuan, up 7.13%, market cap of 181.2 billion yuan [7] Insurance Sector - The financial sector was active, with the insurance sector showing strength. China Life Insurance rose over 3%, reaching 50.94 yuan per share, with a market cap of 1.2794 trillion yuan [10] - China Ping An increased by over 2%, priced at 68.92 yuan per share, with a market cap of 1.2034 trillion yuan [12] - Analysts predict that by 2026, new premium income for listed insurance companies will achieve double-digit growth, driven primarily by the bancassurance channel [15] AI Healthcare Sector - AI healthcare stocks were notably active, with several companies hitting the daily limit up. Notable performers included: - Nossg: 76.48 yuan, up 20.01%, market cap of 7.4 billion yuan - Pruis: 72.24 yuan, up 20.00%, market cap of 5.7 billion yuan - Hongbo Medicine: 56.64 yuan, up 20.00%, market cap of 7.9 billion yuan [18] - Nvidia announced a joint investment of $1 billion with Eli Lilly to establish an AI drug laboratory, which is expected to accelerate medical discoveries [17] Precious Metals Sector - The precious metals sector saw a significant rise, with spot gold prices reaching a record high of $4630.28 per ounce [20] - Key stocks in this sector include: - Hunan Silver: 9.21 yuan, up 9.90%, market cap of 26 billion yuan - Xiaocheng Technology: 38.54 yuan, up 8.72%, market cap of 10.6 billion yuan [21]

有投资者在互动平台向国际医学提问："公司是否直接或间接持有蓝箭航天股份？" 针对上述提问，国际医学回应称："您好，感谢您对公司的关注。公司持有平阳融泰高德股权投资合伙 企业17.5439%的股权，平阳融泰高德股权投资合伙企业持有蓝箭航天0.6889%的股份。谢谢！" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 ...

Group 1 - The stock price of International Medical (000516) closed at 4.93 yuan on January 9, 2026, representing a 14.92% increase from the previous week's price of 4.29 yuan [1] - The highest intraday price for the week was 5.6 yuan on January 7, while the lowest was 4.33 yuan on January 5 [1] - The company recorded two instances of limit-up closing during the week, with no limit-down closures [1] Group 2 - The controlling shareholder, Shaanxi Century Xinyuan Commercial Management Co., Ltd., pledged an additional 800,000 shares, accounting for 0.04% of the total share capital [2][3] - The cumulative pledged shares by Century Xinyuan represent 69.90% of its holdings and 19.23% of the company's total share capital [2][3] - The company stated that this pledge is a supplement to previous pledges and does not involve new financing [2][3]

（编辑 姚尧） 证券日报网讯 1月8日，国际医学在互动平台回答投资者提问时表示，公司始终高度重视提升上市公司 发展质量和市值管理工作。为推动资本市场高质量发展，公司已制定了《市值管理制度》，旨在通过机 制化举措加强市值管理能力，提升公司投资价值。近年来，公司也通过重大资产重组、股权激励、投资 者关系管理、信息披露、股份回购、非公开发行、高管集体增持等多维度措施，积极进行市值管理。本 次发行系基于公司业务发展的需求，最终发行价格将按照相关法律、法规和其他规范性文件的规定，由 公司股东会授权董事会或董事会授权人士根据发行对象申购报价情况及竞价结果，与保荐人（主承销 商）协商确定。 ...

（编辑 袁冠琳） 证券日报网讯 1月7日，国际医学在互动平台回答投资者提问时表示，公司财务状况稳健，经营性现金 流持续为正，资信状况良好，不存在债务风险。公司控股股东及一致行动人资信状况良好，具备较强的 资金偿还能力，质押风险可控。本次非公开发行是为了顺应国家政策，把握"银发经济"发展机遇。优化 资本结构，盘活存量资产，为未来业绩增长奠定坚实基础。 ...

Core Viewpoint - The company has over 20 years of experience in the healthcare industry, focusing on hospital construction, operation, and management [1] Group 1: Company Strategy - The Xi'an International Medical Center Hospital, a significant investment by the company, is a strategic move to establish a comprehensive healthcare platform [1] - The current surplus of hospital beds is part of the developmental process typical for large hospitals [1] - The company anticipates an increase in bed utilization as the hospital's overall strength improves and surrounding areas mature [1] Group 2: Future Outlook - The company plans to continue optimizing resource allocation to enhance operational efficiency [1]

Market Overview - On January 6, the A-share market experienced a broad-based rally, with the Shanghai Composite Index rising by 1.50% to close at 4083.67 points, and the Shenzhen Component Index increasing by 1.40% to 14022.55 points. The total trading volume in the Shanghai and Shenzhen markets reached 2.81 trillion yuan, significantly higher than the previous trading day [1][14]. - The market showed a balanced performance in terms of individual stocks, with 2371 stocks experiencing net inflows from large orders, while 2538 stocks saw net outflows. There was a clear trend of funds concentrating on high-growth sectors and undervalued stocks, indicating significant sector rotation [1][14]. Sector Performance - The non-bank financial sector was the strongest performer, with a net inflow of 6.437 billion yuan and a sector index increase of 3.73%. The metals sector followed closely, rising by 4.26% with a net inflow of 3.663 billion yuan. Other active sectors included optical electronics, chemical raw materials, and minor metals, which also saw significant inflows [1][14]. - Conversely, the telecommunications sector faced substantial outflows, with a net outflow of 7.564 billion yuan. Other sectors such as media, machinery equipment, and pharmaceutical biology also experienced net outflows, indicating a clear adjustment trend [1][14]. Investment Opportunities - **Binhu Chemical (601678)**: A leading chemical company with a focus on low valuation and industry upgrades. The stock hit the daily limit on January 6, closing at 4.75 yuan, with a five-day increase of 10.72%. The company is advancing green low-carbon industrial park construction and digital upgrades, indicating strong valuation recovery potential [2][3]. - **Jiahua Energy (600273)**: A quality energy chemical stock with a complete industrial chain. The stock also hit the daily limit on January 6, closing at 9.59 yuan, with a five-day increase of 14.44%. The company's performance is supported by steady growth and low valuation [4][5]. - **Rainbow Technology (600707)**: A leader in display panels, the stock closed at 7.05 yuan on January 6, with a five-day increase of 12.44%. The company is optimizing its business structure through collaboration with BOE, enhancing its growth prospects [6][7]. Risks in High Valuation Stocks - **International Medical (000516)**: A medical service stock that has shown two consecutive limit-ups but has a significant valuation bubble. The stock closed at 5.19 yuan on January 6, with a five-day increase of 15.59%. The company reported losses, indicating a lack of fundamental support [8][9]. - **Guosheng Technology (603778)**: A new energy stock that has also shown two consecutive limit-ups but lacks performance support. The stock closed at 21.3 yuan on January 6, with a five-day increase of 34.05%. The company continues to report losses, leading to a significant valuation bubble [10][11]. - **Aipeng Medical (300753)**: A medical device stock with high valuation premiums, closing at 39.96 yuan on January 6, with a five-day increase of 38.99%. The company has reported losses, and its stock price is driven by speculative trading rather than fundamental improvements [12][13]. Summary and Investment Strategy - The A-share market is showing a broad rally with significant trading activity, particularly in sectors with clear industrial logic and strong performance certainty. Companies like Binhu Chemical, Jiahua Energy, and Rainbow Technology are highlighted as undervalued opportunities with clear recovery potential [14][15]. - In contrast, stocks like International Medical, Guosheng Technology, and Aipeng Medical are identified as high-risk due to their reliance on speculative trading and lack of fundamental support. Investors are advised to focus on sectors with strong performance certainty while avoiding high-premium stocks lacking earnings support [14][15].

Group 1 - The core viewpoint of the article highlights that International Medical (000516) has established a strong competitive edge and influence in the medical field through significant capital investments in the past [1] - Since the full opening of Xi'an International Medical Center Hospital, the company has experienced substantial growth in overall business scale, with a steady development trend and increasing brand influence and patient recognition [1] - From 2025 onwards, the company has faced a decrease in operating revenue year-on-year due to ongoing adjustments in industry policies, particularly the deepening of medical insurance payment reforms [1] Group 2 - The company will adhere to its strategic development goals, focusing on stable operations, enhancing medical quality and service experience, and building competitive advantages through differentiated strategies [1] - The company aims to actively adapt to industry changes and achieve continuous optimization of operational efficiency and improvement in business performance [1]